Ginkgo Bioworks Holdings, Inc. - Class A Common Stock, $0.0001 par value per share (DNA)

Historical Holders from Q2 2024 to Q4 2025

Type / Class
Equity / Class A Common Stock, $0.0001 par value per share
Symbol
DNA on NYSE
Shares outstanding
48,288,480
Price per share
$8.31
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares as of 30 Sep 2025
30,191,452
Total reported value
$437,213,076
% of total 13F portfolios
0%
Share change
-3,023,619
Value change
-$36,393,470
Avg buy value change
+0%
Avg sell value change
-0%
Number of holders
172
Price from insider filings
$8.89
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Ginkgo Bioworks Holdings, Inc. - Class A Common Stock, $0.0001 par value per share (DNA) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Shetty Reshma P. 9.5% $38,294,602 4,716,084 Reshma P. Shetty 14 Feb 2025
CASCADE INVESTMENT, L.L.C. 7.5% $52,803,453 3,621,636 Cascade Investment, L.L.C. 30 Sep 2025
BlackRock, Inc. 6.5% $24,373,341 3,001,643 BlackRock, Inc. 30 Jun 2025
VANGUARD GROUP INC 5.1% +17% $19,334,654 +$2,984,644 2,381,115 +18% The Vanguard Group 30 Jun 2025
Che Austin 5% $19,265,293 2,372,573 Austin Che 31 Dec 2024
As of 30 Sep 2025, Ginkgo Bioworks Holdings, Inc. - Class A Common Stock, $0.0001 par value per share (DNA) has 172 institutional shareholders filing 13F forms. They hold 30,191,452 shares of 48,288,480 outstanding shares (63%) .

Top 25 institutional shareholders own 56% of the company.

Filer Ownership Nb Shares Share Change % Portfolio % Holdings Value
VIKING GLOBAL INVESTORS LP 7.4% 3,577,128 0% 0.14% $52,154,526
BlackRock, Inc. 7.1% 3,417,996 +12% 0% $49,834,382
BAILLIE GIFFORD & CO 6.7% 3,235,254 -1.2% 0.03% $47,170,004
VANGUARD GROUP INC 5.1% 2,480,504 +4.2% 0% $36,165,749
Erste Asset Management GmbH 4.6% 2,200,000 +10% 0.28% $29,106,000
Anchorage Capital Group, L.L.C. 3.6% 1,746,363 0% 22% $25,461,973
Legal & General Group Plc 3.3% 1,608,923 +7.9% 0.01% $23,458,008
BANK OF AMERICA CORP /DE/ 2.2% 1,068,575 -11% 0% $15,579,824
FORBES J M & CO LLP 2.2% 1,060,341 -1.6% 1.3% $15,459,772
STATE STREET CORP 1.9% 933,840 +26% 0% $13,615,387
GOLDMAN SACHS GROUP INC 1.7% 825,288 -28% 0% $12,032,699
GEODE CAPITAL MANAGEMENT, LLC 1.7% 808,360 -14% 0% $11,788,300
SB INVESTMENT ADVISERS (UK) LTD 1.3% 610,729 0% 0.07% $8,904,429
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 0.71% 343,558 +3.6% 0% $5,009,076
Ensign Peak Advisors, Inc 0.69% 335,073 +1.3% 0.01% $4,885,364
EXCHANGE TRADED CONCEPTS, LLC 0.69% 332,168 +12% 0.05% $4,843,009
NORTHERN TRUST CORP 0.67% 325,508 +2.1% 0% $4,745,907
MORGAN STANLEY 0.66% 320,722 -37% 0% $4,676,128
Coastal Bridge Advisors, LLC 0.57% 276,817 0% 0.31% $4,035,992
UBS Group AG 0.54% 262,557 -16% 0% $3,828,080
Lingotto Investment Management LLP 0.52% 250,282 0% 0.07% $3,649,112
SUSQUEHANNA INTERNATIONAL GROUP, LLP 0.49% 237,058 +27% 0.01% $3,456,306
Invesco Ltd. 0.44% 211,141 +32% 0% $3,078,436
Allianz Asset Management GmbH 0.4% 192,160 0% $2,801,693
BNP PARIBAS FINANCIAL MARKETS 0.38% 185,683 0% 0% $2,707,258

Institutional Holders of Ginkgo Bioworks Holdings, Inc. - Class A Common Stock, $0.0001 par value per share (DNA) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price Investors
2025 Q4 14,937 $124,126 -$206,401 $8.31 4
2025 Q3 30,191,452 $437,213,076 -$36,393,470 $14.58 172
2025 Q2 33,351,676 $375,205,711 +$29,774,147 $11.25 164
2025 Q1 32,270,574 $183,952,552 -$9,250,063 $5.70 161
2024 Q4 32,507,917 $318,926,648 +$61,124,926 $9.82 159
2024 Q3 26,309,917 $214,342,391 +$204,195,190 $8.15 152
2024 Q2 12,000 $4,012 +$4,012 $0.3343 1